Medindia
Medindia LOGIN REGISTER
Advertisement

SOM Biotech Licenses its First Product and Expands to the United States

Tuesday, July 25, 2017 Medico Legal News
Advertisement
- SOM's has granted a worldwide exclusive license to Corino Therapeutics Inc. following clinical Phase 2 testing of its lead compound SOM0266 for the treatment of TTR Amyloidosis.

Sponsored Post and Backlink Submission


Latest Press Release on Medico Legal News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close